Based on the key indicators related to Haemonetics' liquidity, profitability, solvency, and operating efficiency, Haemonetics may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, Haemonetics' Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 198.3 M, whereas Total Stockholder Equity is forecasted to decline to about 546.7 M.
The financial analysis of Haemonetics is a critical element in measuring its lifeblood. Investors should carefully consider Haemonetics' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Understanding current and past Haemonetics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Haemonetics' financial statements are interrelated, with each one affecting the others. For example, an increase in Haemonetics' assets may result in an increase in income on the income statement.
Please note, the presentation of Haemonetics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Haemonetics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Haemonetics' management manipulating its earnings.
Haemonetics Stock Summary
Haemonetics competes with Inspira Technologies, Tenon Medical, Biomerica, Heart Test, and STRATA Skin. Haemonetics Corporation, a healthcare company, provides medical products and solutions. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts. Haemonetics Corp operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 2821 people.
Comparative valuation techniques use various fundamental indicators to help in determining Haemonetics's current stock value. Our valuation model uses many indicators to compare Haemonetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Haemonetics competition to find correlations between indicators driving Haemonetics's intrinsic value. More Info.
Haemonetics is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.33 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Haemonetics is roughly 2.99 . At present, Haemonetics' Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Haemonetics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Most indicators from Haemonetics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Haemonetics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Haemonetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Haemonetics is part of several thematic ideas from Obamacare Repeal to Baby Boomer Prospects. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Along with financial statement analysis, the daily predictive indicators of Haemonetics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Haemonetics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Haemonetics based on widely used predictive technical indicators. In general, we focus on analyzing Haemonetics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Haemonetics's daily price indicators and compare them against related drivers.
Complementary Tools for Haemonetics Stock analysis
When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.